{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:42:59Z","timestamp":1790023379142,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Salivary gland dysfunction (e.g., sialadenitis and xerostomia) is the most common complication of radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC). Several methods have been used to reduce\/prevent this adverse effect. We aimed to systematically review the effectiveness of non-pharmacological and pharmacological interventions in preventing RAI-induced salivary gland dysfunction in patients with DTC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review was conducted, according to PRISMA guidelines. The protocol was registered (PROSPERO: CRD42022295229). PubMed, Embase, Scopus, and the Cochrane Library electronic databases were searched from inception to November 2021. Inclusion criteria were randomized controlled trials of DTC patients who were older than 18 years and underwent RAI after thyroidectomy in which at least one studied group received an intervention to prevent salivary gland dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twelve studies (a total of 667 participants) were included. Among DTC patients who were treated with RAI, nonpharmacological treatment such as parotid gland massage and aromatherapy ameliorated salivary gland dysfunction. Antioxidants such as vitamin E and selenium demonstrated radioprotective effects on the salivary gland, while other antioxidants did not show radioprotective benefits. Vitamin C showed no significant effects on preventing salivary gland dysfunction. Amifostine had inconsistent outcomes among studies. Among cholinergic agonists, pilocarpine did not demonstrate the radioprotective effect on parotid glands, while bethanechol lowered salivary gland dysfunction. However, the negative results from pilocarpine may be explained by the strong sialorrheic effect of the Cincinnati regimen in both study arms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among non-pharmacological and pharmacological methods, parotid gland massage, aromatherapy, vitamin E, selenium, amifostine, and bethanechol may have benefits in minimizing RAI-induced salivary gland dysfunction in patients with DTC. The results are limited by a small number of patients and should be confirmed in future larger randomized controlled trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=295229<\/jats:uri>, PROSPERO, identifier CRD42022295229.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.960265","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T06:18:54Z","timestamp":1661753934000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Arunrat","family":"Auttara-atthakorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaruwan","family":"Sungmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunyarat","family":"Anothaisintawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirimon","family":"Reutrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutintorn","family":"Sriphrapradang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0883-1","article-title":"Guidelines for radioiodine therapy of differentiated thyroid cancer","volume":"35","author":"Luster","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-200211000-00003","article-title":"Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment","volume":"27","author":"Caglar","year":"2002","journal-title":"Clin Nucl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/105072503321582060","article-title":"Radioactive iodine and the salivary glands","volume":"13","author":"Mandel","year":"2003","journal-title":"Thyroid"},{"key":"B5","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander","year":"1998","journal-title":"J Nucl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.endonu.2015.07.006","article-title":"Sialadenitis after radioiodine therapy. analysis of factors that influence the response to medical treatment","volume":"62","author":"Geres","year":"2015","journal-title":"Endocrinol Nutr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.clinimag.2014.12.018","article-title":"Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: Emphasis on radioactive iodine therapy dose","volume":"39","author":"Lee","year":"2015","journal-title":"Clin Imaging"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2020.1802507","article-title":"Incidence and risk factors for radioactive iodine-induced sialadenitis","volume":"140","author":"Sanchez Barrueco","year":"2020","journal-title":"Acta Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4158\/EP10170.RA","article-title":"Early and late toxicity of radioiodine therapy: Detection and management","volume":"16","author":"Hyer","year":"2010","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2010.01726.x","article-title":"Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer","volume":"17","author":"Van Nostrand","year":"2011","journal-title":"Oral Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200608000-00009","article-title":"Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer","volume":"27","author":"Jentzen","year":"2006","journal-title":"Nucl Med Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.mnm.0000202864.52046.b1","article-title":"Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands","volume":"27","author":"Anjos","year":"2006","journal-title":"Nucl Med Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/TCRM.S76282","article-title":"Diagnosis and management of xerostomia and hyposalivation","volume":"11","author":"Villa","year":"2015","journal-title":"Ther Clin Risk Manage"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181068","article-title":"Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy","volume":"21","author":"Becciolini","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"B15","first-page":"77","article-title":"Evaluation of a number of blood biochemical markers after radioiodine therapy in papillary thyroid cancer patients","volume":"8","author":"Alavi","year":"2017","journal-title":"Middle East J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6795076","DOI":"10.1155\/2016\/6795076","article-title":"Clinical studies of nonpharmacological methods to minimize salivary gland damage after radioiodine therapy of differentiated thyroid carcinoma: Systematic review","volume":"2016","author":"Christou","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000176","article-title":"Emptying effect of massage on parotid gland radioiodine content","volume":"35","author":"Hong","year":"2014","journal-title":"Nucl Med Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002602","article-title":"The preventive effect of parotid gland massage on salivary gland dysfunction during high-dose radioactive iodine therapy for differentiated thyroid cancer: A randomized clinical trial","volume":"44","author":"Son","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9509810","DOI":"10.1155\/2016\/9509810","article-title":"A randomized controlled trial for the effectiveness of aromatherapy in decreasing salivary gland damage following radioactive iodine therapy for differentiated thyroid cancer","volume":"2016","author":"Nakayama","year":"2016","journal-title":"BioMed Res Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.071449","article-title":"Influence of vitamin c on salivary absorbed dose of 131I in thyroid cancer patients: A prospective, randomized, single-blind, controlled trial","volume":"51","author":"Liu","year":"2010","journal-title":"J Nucl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328362b1f2","article-title":"Does vitamin e protect salivary glands from I-131 radiation damage in patients with thyroid cancer","volume":"34","author":"Fallahi","year":"2013","journal-title":"Nucl Med Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/MNM.0000000000000727","article-title":"Radioprotective effect of vitamin e on salivary glands after radioiodine therapy for differentiated thyroid cancer: A randomized-controlled trial","volume":"38","author":"Upadhyaya","year":"2017","journal-title":"Nucl Med Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1967\/s002449910508","article-title":"Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer","volume":"20","author":"Son","year":"2017","journal-title":"Hell J Nucl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0191","article-title":"Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan","volume":"18","author":"Kim","year":"2008","journal-title":"Thyroid"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000820","article-title":"Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine","volume":"39","author":"Haghighatafshar","year":"2018","journal-title":"Nucl Med Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.11.3542","article-title":"Salivary gland protection by amifostine in high-dose radioiodine treatment: Results of a double-blind placebo-controlled study","volume":"16","author":"Bohuslavizki","year":"1998","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.049411","article-title":"Reducing the incidence of 131I-induced sialadenitis: the role of pilocarpine","volume":"49","author":"Silberstein","year":"2008","journal-title":"J Nucl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2021.12.014.","article-title":"Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: A double blind, placebo-controlled, randomized study","author":"Campanha","year":"2021","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0188","article-title":"Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake","volume":"22","author":"Kim","year":"2012","journal-title":"Thyroid"},{"key":"B31","article-title":"Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer","volume":"46","author":"Nakada","year":"2005","journal-title":"J Nucl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00411-018-0744-7","article-title":"The evaluation of protective and mitigating effects of vitamin c against side effects induced by radioiodine therapy","volume":"57","author":"Jafari","year":"2018","journal-title":"Radiat Environ Biophys"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9290.42953","article-title":"Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer","volume":"19","author":"Chitra","year":"2008","journal-title":"Indian J Dent Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1748-717X-9-125","article-title":"Updates on clinical studies of selenium supplementation in radiotherapy","volume":"9","author":"Puspitasari","year":"2014","journal-title":"Radiat Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3857\/roj.2015.33.2.66","article-title":"The protective effects of trace elements against side effects induced by ionizing radiation","volume":"33","author":"Hosseinimehr","year":"2015","journal-title":"Radiat Oncol J"},{"key":"B36","article-title":"Limited effects of selenium substitution in the prevention of radiation-associated toxicities. Results of a randomized study in head and neck cancer patients","volume":"30","author":"Buntzel","year":"2010","journal-title":"Anticancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2004.03.015","article-title":"The potential influence of cell protectors for dose escalation in cancer therapy: An analysis of amifostine","volume":"29","author":"McCumber","year":"2004","journal-title":"Med Dosim"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1368-6","article-title":"Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer","volume":"37","author":"Ma","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549010-00010","article-title":"Oral pilocarpine: A review of its pharmacological properties and clinical potential in xerostomia","volume":"49","author":"Wiseman","year":"1995","journal-title":"Drugs"},{"key":"B40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1601-0825.2005.01195.x","article-title":"Pilocarpine for the treatment of salivary glands\u2019 impairment caused by radioiodine therapy for thyroid cancer","volume":"12","author":"Aframian","year":"2006","journal-title":"Oral Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.01.013","article-title":"A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer","volume":"43","author":"Jham","year":"2007","journal-title":"Oral Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.03.017","article-title":"Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients","volume":"115","author":"Jaguar","year":"2015","journal-title":"Radiother Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8649794","article-title":"Early sialadenitis after radioactive iodine therapy for differentiated thyroid cancer: Prevalence and predictors","volume":"2020","author":"Riachy","year":"2020","journal-title":"Int J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.960265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T06:19:02Z","timestamp":1661753942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.960265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.960265"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.960265","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"article-number":"960265"}}